These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10502732)

  • 21. Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.
    Hotakainen K; Lintula S; Ljungberg B; Finne P; Paju A; Stenman UH; Stenman J
    J Mol Diagn; 2006 Nov; 8(5):598-603. PubMed ID: 17065429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma.
    Goldman S; Svensson C; Brönnergård M; Glimelius B; Wallin G
    Int J Colorectal Dis; 1993 Jul; 8(2):98-102. PubMed ID: 7691975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma.
    Yasumatsu R; Nakano T; Hashimoto K; Kogo R; Wakasaki T; Nakagawa T
    Auris Nasus Larynx; 2019 Feb; 46(1):135-140. PubMed ID: 30078551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
    Lempiäinen A; Stenman UH; Blomqvist C; Hotakainen K
    Clin Chem; 2008 Nov; 54(11):1840-3. PubMed ID: 18787014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical usage of the squamous cell carcinoma antigen in patients with penile cancer.
    Touloupidis S; Zisimopoulos A; Giannakopoulos S; Papatsoris AG; Kalaitzis C; Thanos A
    Int J Urol; 2007 Feb; 14(2):174-6. PubMed ID: 17302580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
    Chen CH; Tsai TL; Yang YS; Tsai CC
    J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.
    Glaser CM; Millesi W; Kornek GV; Lang S; Schüll B; Watzinger F; Selzer E; Lavey RS
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):705-15. PubMed ID: 11395239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance of Cytokeratin 19 and Squamous Cell Cancer Antigen in Histologically Negative Sentinel Lymph Nodes of Cervical Squamous Cell Carcinoma.
    Ren J; Zhou ZL; Xu S; Yang YJ
    Int J Gynecol Cancer; 2016 Nov; 26(9):1679-1685. PubMed ID: 27654256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Squamous cell carcinoma associated antigen levels in monitoring the response to surgical treatment for patients with esophageal carcinoma].
    Zeng L
    Zhonghua Yi Xue Za Zhi; 1993 Aug; 73(8):469-70, 510. PubMed ID: 8111645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of serum liver enzymes in oral and oropharynx squamous cell carcinomas.
    Zhu Z; Zhou J; Xiong X; Liu D; Zheng Y; Ding X; Du Y; Gu N; Wu Y; Song X
    J Oral Pathol Med; 2019 Jan; 48(1):36-42. PubMed ID: 30447114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
    Nagumo K; Okada N; Takagi M; Yamamoto H; Amagasa T; Fujibayashi T
    Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):27-34. PubMed ID: 2225283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.
    Agra IM; Carvalho AL; Ulbrich FS; de Campos OD; Martins EP; Magrin J; Kowalski LP
    Head Neck; 2006 Feb; 28(2):107-13. PubMed ID: 16388526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of preoperative C-reactive protein and squamous cell carcinoma antigen levels in patients with penile squamous cell carcinoma.
    Li ZS; Yao K; Li YH; Chen JP; Deng CZ; Zhao Q; Chen P; Wang B; Mi QW; Liu ZW; Qin ZK; Han H; Zhou FJ
    BJU Int; 2016 Aug; 118(2):272-8. PubMed ID: 26573952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyfra 21-1 as a tumor marker for follow-up of patients with squamous cell carcinoma of the oropharynx.
    Alkotyfan K; Wiegand S; Müller HH; Windfuhr JP; Werner JA; Sesterhenn AM
    Anticancer Res; 2010 Jun; 30(6):2291-6. PubMed ID: 20651382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective cohort study of prognostic factors in patients with oral cavity and oropharyngeal squamous cell carcinoma.
    Carrillo JF; Carrillo LC; Cano A; Ramirez-Ortega MC; Chanona JG; Avilés A; Herrera-Goepfert R; Corona-Rivera J; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Head Neck; 2016 Apr; 38(4):536-41. PubMed ID: 25351827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
    Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
    Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.